Feb 25 (Reuters) - Terns Pharmaceuticals Inc TERN.O:
TERNS PHARMACEUTICALS: CASH & CASH EQUIVALENTS EXPECTED TO PROVIDE RUNWAY INTO 2028
TERNS PHARMACEUTICALS: ON TRACK TO INITIATE TERN-601 PHASE 2 FALCON STUDY IN EARLY 2Q25 WITH 12-WEEK DATA EXPECTED 2H25
Source text: ID:nGNX3SVjhF
Further company coverage: TERN.O
((Reuters.Briefs@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.